FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382011672> ?p ?o ?g. }

• W4382011672 abstract "Abstract Context Acromegaly is a rare, chronic, debilitating disorder caused by prolonged hypersecretion of growth hormone (GH) and overproduction of insulin-like growth factor I (IGF-I). Medical therapies, including the somatostatin receptor ligand (SRL) pasireotide, are frequently used to restore biochemical control. Objective As patients often receive therapy over prolonged periods, long-term data from real-life settings are needed. Methods A retrospective analysis was performed using a prospectively maintained database of all patients with acromegaly from our primary care center who were enrolled in clinical studies with pasireotide (first visit November 2008). The main outcome measures were safety and biochemical control (age-adjusted IGF-I ≤ upper limit of normal). Results Patients (n = 50) entered 4 parental studies and 30 continued in the rollover; at data cutoff (June 2022), 27 were still receiving pasireotide. Overall, median (range) exposure was 58 (3-137) months. Normal IGF-I was achieved in 54%, and acromegaly symptoms and quality of life were improved with treatment. No predictors of pasireotide response were identified; however, controlled patients had smaller tumors and lower GH at baseline. Tumor volume reduction occurred in 63% of evaluable patients (n = 10/16). Most patients presented hyperglycemic events, including 63.2% of patients with normal glucose before treatment. Older patients and those with higher IGF-I, glucose, and HbA1c at baseline had higher glucose and HbA1c during pasireotide treatment. Conclusion Pasireotide provided clinical benefit and was well tolerated for more than 11 years of treatment in acromegaly patients, most of whom were resistant to first-generation SRLs." @default.
• W4382011672 created "2023-06-27" @default.
• W4382011672 creator A5005427047 @default.
• W4382011672 creator A5014726016 @default.
• W4382011672 creator A5037475854 @default.
• W4382011672 creator A5038198389 @default.
• W4382011672 creator A5049125279 @default.
• W4382011672 creator A5061840145 @default.
• W4382011672 creator A5072046614 @default.
• W4382011672 creator A5077289931 @default.
• W4382011672 creator A5092262223 @default.
• W4382011672 date "2023-06-26" @default.
• W4382011672 modified "2023-10-03" @default.
• W4382011672 title "Long-term Efficacy and Safety of Pasireotide in Patients With Acromegaly: 14 Years of Single-Center Real-World Experience" @default.
• W4382011672 cites W1827628447 @default.
• W4382011672 cites W1966885478 @default.
• W4382011672 cites W1970121215 @default.
• W4382011672 cites W1996943463 @default.
• W4382011672 cites W2050501224 @default.
• W4382011672 cites W2054935117 @default.
• W4382011672 cites W2069900263 @default.
• W4382011672 cites W2101992531 @default.
• W4382011672 cites W2125103450 @default.
• W4382011672 cites W2155465275 @default.
• W4382011672 cites W2168543315 @default.
• W4382011672 cites W2168906621 @default.
• W4382011672 cites W2325194403 @default.
• W4382011672 cites W2599226646 @default.
• W4382011672 cites W2783104796 @default.
• W4382011672 cites W2796015429 @default.
• W4382011672 cites W2884285576 @default.
• W4382011672 cites W2889103264 @default.
• W4382011672 cites W2922411699 @default.
• W4382011672 cites W2935406275 @default.
• W4382011672 cites W3012988984 @default.
• W4382011672 cites W3021053066 @default.
• W4382011672 cites W3086932070 @default.
• W4382011672 cites W3095629790 @default.
• W4382011672 cites W3134069441 @default.
• W4382011672 cites W3164420517 @default.
• W4382011672 cites W3203914138 @default.
• W4382011672 cites W4281641558 @default.
• W4382011672 cites W4307031722 @default.
• W4382011672 cites W437706838 @default.
• W4382011672 doi "https://doi.org/10.1210/clinem/dgad378" @default.
• W4382011672 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37357993" @default.
• W4382011672 hasPublicationYear "2023" @default.
• W4382011672 type Work @default.
• W4382011672 citedByCount "1" @default.
• W4382011672 countsByYear W43820116722023 @default.
• W4382011672 crossrefType "journal-article" @default.
• W4382011672 hasAuthorship W4382011672A5005427047 @default.
• W4382011672 hasAuthorship W4382011672A5014726016 @default.
• W4382011672 hasAuthorship W4382011672A5037475854 @default.
• W4382011672 hasAuthorship W4382011672A5038198389 @default.
• W4382011672 hasAuthorship W4382011672A5049125279 @default.
• W4382011672 hasAuthorship W4382011672A5061840145 @default.
• W4382011672 hasAuthorship W4382011672A5072046614 @default.
• W4382011672 hasAuthorship W4382011672A5077289931 @default.
• W4382011672 hasAuthorship W4382011672A5092262223 @default.
• W4382011672 hasBestOaLocation W43820116721 @default.
• W4382011672 hasConcept C126322002 @default.
• W4382011672 hasConcept C134018914 @default.
• W4382011672 hasConcept C151730666 @default.
• W4382011672 hasConcept C159110408 @default.
• W4382011672 hasConcept C2776297358 @default.
• W4382011672 hasConcept C2777433750 @default.
• W4382011672 hasConcept C2778886798 @default.
• W4382011672 hasConcept C2779343474 @default.
• W4382011672 hasConcept C2779371878 @default.
• W4382011672 hasConcept C2779951463 @default.
• W4382011672 hasConcept C2781025020 @default.
• W4382011672 hasConcept C2984496839 @default.
• W4382011672 hasConcept C71315377 @default.
• W4382011672 hasConcept C71924100 @default.
• W4382011672 hasConcept C86803240 @default.
• W4382011672 hasConcept C90924648 @default.
• W4382011672 hasConceptScore W4382011672C126322002 @default.
• W4382011672 hasConceptScore W4382011672C134018914 @default.
• W4382011672 hasConceptScore W4382011672C151730666 @default.
• W4382011672 hasConceptScore W4382011672C159110408 @default.
• W4382011672 hasConceptScore W4382011672C2776297358 @default.
• W4382011672 hasConceptScore W4382011672C2777433750 @default.
• W4382011672 hasConceptScore W4382011672C2778886798 @default.
• W4382011672 hasConceptScore W4382011672C2779343474 @default.
• W4382011672 hasConceptScore W4382011672C2779371878 @default.
• W4382011672 hasConceptScore W4382011672C2779951463 @default.
• W4382011672 hasConceptScore W4382011672C2781025020 @default.
• W4382011672 hasConceptScore W4382011672C2984496839 @default.
• W4382011672 hasConceptScore W4382011672C71315377 @default.
• W4382011672 hasConceptScore W4382011672C71924100 @default.
• W4382011672 hasConceptScore W4382011672C86803240 @default.
• W4382011672 hasConceptScore W4382011672C90924648 @default.
• W4382011672 hasFunder F4320332736 @default.
• W4382011672 hasLocation W43820116721 @default.
• W4382011672 hasLocation W43820116722 @default.
• W4382011672 hasOpenAccess W4382011672 @default.
• W4382011672 hasPrimaryLocation W43820116721 @default.
• W4382011672 hasRelatedWork W1982345662 @default.
• W4382011672 hasRelatedWork W2064770466 @default.

• next